CHYM · trading date Oct 12, 2026 · previous close $30.08 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$2.19B
Net income
-$1.01B
Total assets
$1.96B
Total liabilities
$562.90M
Stockholders' equity
$1.40B
Cash & equivalents
$466.25M
Operating income
-$1.04B
Operating cash flow
$52.78M
Capital expenditures
$19.89M
Fiscal year 2025, via 10-K filed 2026-03-06.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-47.6%
Net margin
-46.2%
Free cash flow
$32.89M
Free cash flow margin
1.5%
Liabilities / assets
28.7%
Equity / assets
71.3%
CapEx / revenue
0.9%
Operating cash flow / net income
-0.05×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
San Francisco, CA 94111
101 CALIFORNIA STREET, SUITE 500
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.